Claudia A. Angeli, V. Reggie Edgerton, Yury P. Gerasimenko, Susan J. Harkema. Altering spinal cord excitability enables voluntary movements after chronic complete paralysis in humans. Brain 2014; 137: 1394–1409; 10.1093/brain/awu038.
The authors would like to apologize for omission of the following conflict of interest statement:
Conflict of interest
Dr V. Reggie Edgerton, along with Dr Yury Gerasimenko, researchers on the study team, hold shareholder interest in NeuroRecovery Technologies. Dr Edgerton is also President and Chair of the company’s Board of Directors. Drs Edgerton and Gerasimenko hold certain inventorship rights on intellectual property licensed by The Regents of the University of California to NeuroRecovery Technologies and its subsidiaries.